• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.13% Nasdaq Up 0.70%

    Celsion Corp. (CLSN)

    -NasdaqCM
    2.33 Down 0.06(2.51%) Dec 26, 4:00PM EST
    Add to Portfolio
    Prev Close:2.39
    Open:2.37
    Bid:N/A
    Ask:2.65 x 1200
    1y Target Est:7.33
    Beta:0.98
    Earnings Date:Mar 11 - Mar 16 (Est.)
    Day's Range:2.33 - 2.42
    52wk Range:2.30 - 4.74
    Volume:156,160
    Avg Vol (3m):78,154
    Market Cap:46.54M
    P/E (ttm):N/A
    EPS (ttm):-1.26
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CLSN

    Comparison

    Symbol% ChgMkt Cap
    CLSNDown 2.51%46.54M
    BSDMDown 2.48%12.50M
    DCTHDown 0.74%12.75M
    MMSIUp 1.05%753.02M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):95.49
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.42
    Quarterly EPS Est (Dec-14) :-0.36
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Celsion Corporation, an oncology drug development company, focuses on the development and commercialization of chemotherapeutic oncology drugs based on its proprietary heat-activated liposomal technology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback